Destruction of the architectural and subsequently the functional integrity of the lung following pulmonary viral infections is attributable to both the extent of pathogen replication and to the host-generated inflammation associated with the recruitment of immune responses. The presence of antigenically disparate pulmonary viruses and the emergence of novel viruses assures the recurrence of lung damage with infection and resolution of each primary viral infection. Thus, there is a need to develop safe broad spectrum immunoprophylactic strategies capable of enhancing protective immune responses in the lung but which limits immune-mediated lung damage. The immunoprophylactic strategy described here utilizes a protein cage nanoparticle (PCN) to significantly accelerate clearance of diverse respiratory viruses after primary infection and also results in a host immune response that causes less lung damage.
Article
Inducible Bronchus-Associated Lymphoid Tissue Elicited by a Protein Cage Nanoparticle Enhances Protectionin Mice against Diverse Respiratory Viruses
Inducible Bronchus-Associated Lymphoid Tissue Elicited by a Protein Cage Nanoparticle Enhances Protectionin Mice against Diverse Respiratory Viruses
Document Type
Article
Publisher
PLOS One
Publication Date
1-1-2009
Disciplines
Abstract
Citation Information
Wiley, J.A., Richert, L.E., Swain, S.D., Harmsen, A., Barnard, D.L., Randall, T. D., Jutila,
M., Douglas, T., Broomell, C., Young, M., and Harmsen, A. 2009. Inducible Bronchus-
Associated Lymphoid Tissue Elicited by a Protein Cage Nanoparticle Enhances Protection
in Mice against Diverse Respiratory Viruses. PLoS ONE 4: e7142.
doi:10.1371/journal.pone.0007142. PMID: 19774076
PLoS ONE 4: e7142. doi:10.1371/journal.pone.0007142. PMID: 19774076